Steatorrhea risk factors: Difference between revisions
Jump to navigation
Jump to search
| Line 7: | Line 7: | ||
==Risk Factors== | ==Risk Factors== | ||
Common risk factors in the development of Steatorrhea include: | *Common risk factors in the development of Steatorrhea include: | ||
**[[Celiac disease]] | **[[Celiac disease]] | ||
**[[Cystic fibrosis]]<ref name="pmid21493738">{{cite journal |vauthors=Pillarisetti N, Williamson E, Linnane B, Skoric B, Robertson CF, Robinson P, Massie J, Hall GL, Sly P, Stick S, Ranganathan S |title=Infection, inflammation, and lung function decline in infants with cystic fibrosis |journal=Am. J. Respir. Crit. Care Med. |volume=184 |issue=1 |pages=75–81 |year=2011 |pmid=21493738 |doi=10.1164/rccm.201011-1892OC |url=}}</ref> | **[[Cystic fibrosis]]<ref name="pmid21493738">{{cite journal |vauthors=Pillarisetti N, Williamson E, Linnane B, Skoric B, Robertson CF, Robinson P, Massie J, Hall GL, Sly P, Stick S, Ranganathan S |title=Infection, inflammation, and lung function decline in infants with cystic fibrosis |journal=Am. J. Respir. Crit. Care Med. |volume=184 |issue=1 |pages=75–81 |year=2011 |pmid=21493738 |doi=10.1164/rccm.201011-1892OC |url=}}</ref> | ||
Revision as of 15:45, 8 February 2018
|
Steatorrhea Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Steatorrhea risk factors On the Web |
|
American Roentgen Ray Society Images of Steatorrhea risk factors |
|
Risk calculators and risk factors for Steatorrhea risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
Common risk factors in the development of steatorrhea include: Celiac disease, cystic fibrosis, exocrine pancreatic insufficiency, inflammatory bowel disease, small intestinal bacterial overgrowth, hypolipidemic drugs
Risk Factors
- Common risk factors in the development of Steatorrhea include:
- Celiac disease
- Cystic fibrosis[1]
- Exocrine pancreatic insufficieny
- Inflammatory bowel disease
- Small intestinal bacterial overgrowth
- Hypolipidemic drugs
References
- ↑ Pillarisetti N, Williamson E, Linnane B, Skoric B, Robertson CF, Robinson P, Massie J, Hall GL, Sly P, Stick S, Ranganathan S (2011). "Infection, inflammation, and lung function decline in infants with cystic fibrosis". Am. J. Respir. Crit. Care Med. 184 (1): 75–81. doi:10.1164/rccm.201011-1892OC. PMID 21493738.